Oncology, cancer prevention, tumor biology, and immunotherapy relevant to longevity
316 articles
Nationwide French study reveals benzodiazepine use significantly worsens survival outcomes in lung cancer patients receiving pembrolizumab immunotherapy.
New fusion model combines hypoxia and immune markers to predict hepatocellular carcinoma treatment success non-invasively.
Trastuzumab deruxtecan demonstrates potential benefits in treating residual HER2-positive early breast cancer patients.
Engineered immune cell vesicles first induce cancer cell senescence with chemo, then eliminate them with targeted senolytic drugs.
New research reveals how α-ketoglutarate regulates AMPK synthesis, offering potential cancer therapy targets through energy stress.
Comprehensive analysis reveals dramatic increase in breast cancer cases worldwide, with developing regions facing steepest rises.
Scientists discover how tumor lactate weakens immune cells and identify supplement combo that restores cancer-fighting power.
Comprehensive review reveals increasing GEP-NET incidence and advances in endoscopic diagnosis and targeted therapies for these diverse tumors.
Researchers identify distinct EBV-positive gastric cancer subtypes with specific therapeutic vulnerabilities for precision treatment.
New research reveals how cannabidiol suppresses cancer cell invasion through MALAT1 and mTOR signaling pathways.
Researchers developed a new radiotracer that targets cancer cells more effectively when combined with mTOR inhibition therapy.
Metabolite supplement protects heart from chemo toxicity and enhances tumor suppression in breakthrough dual-action study.
